PANCREATIC CANCER MRNA VACCINE SHOWS LASTING RESULTS IN AN EARLY TRIAL

Summary from the TLDR newsletter

mRNA vaccines, personalized for each individual using genetic material taken from their unique tumor cells, are showing promise in the fight against pancreatic cancer. These vaccines work as a type of immunotherapy that stamps out lingering, undetected cancer cells after surgery to remove larger tumors. Traditional immunotherapies only work in about 20% of all cancers, and pancreatic cancer is the poster child for difficult-to-treat cancers. The drugmakers behind the vaccine have now started Phase 2 clinical trials.